• Clinical Trials

    Prostate Cancer Survivorship Study is Now Open – Enroll Now!

    by  • March 8, 2014 • Clinical Trials, Coping with Cancer, Prostate Cancer

    I and my research staff at Fox Chase Cancer Center have recently launched a new study called PROGRESS (Prostate Cancer Online Guide& Resources for Electronic Survivorship Service) for men who have completed prostate cancer treatment within the last year. The purpose is to assess a new program designed to help men set wellness goals...

    Read more →

    Customized Kidney Cancer Treatment, Tailor Made for Each Patient

    by  • July 23, 2013 • Cancer Vaccines, Clinical Trials, Kidney Cancer, Surgery

    The recent work of The Cancer Genome Atlas (TCGA) showing the underlying genetic changes for kidney cancer is groundbreaking, and it will lead to major progress in kidney cancer treatment (see related blog). But another exciting new therapy is already available today, and it captures the goals of “personalized medicine”— aiming for a uniquely...

    Read more →

    Patients’ Genes Provide a Blueprint for Hope in Cancer Treatment

    by  • April 22, 2013 • Cancer Genome Institute, Cancer Staging, Clinical Trials, Genetic Counseling

    A article in yesterday’s  New York Times (“Cancer Centers Racing to Map Patients’ Genes” April 21, 2013) discusses the emerging importance of gene mapping in determining precise medical treatment. Fox Chase Cancer Center has been pursuing this course of treatment for oncology patients, plotting a genetic “blueprint” for targeting treatment in advanced cancers. The...

    Read more →

    FDA Approves New Drug for Breast Cancer

    by  • February 26, 2013 • Breast Cancer Treatment, Clinical Trials, News, Scientific Research, Uncategorized

    About 20 percent of breast cancers have an increase in the amount of a protein called HER2.  HER2 is a protein involved in normal cell growth. It is found in increased amounts on some types of cancer cells (HER2-positive), including some breast cancers. In these HER2-positive breast cancers, the increased amount of the HER2...

    Read more →